These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15699273)

  • 1. Age and time need not and should not be eliminated from the coronary risk prediction models.
    Vasan RS; D'Agostino RB
    Circulation; 2005 Feb; 111(5):542-5. PubMed ID: 15699273
    [No Abstract]   [Full Text] [Related]  

  • 2. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program.
    Ridker PM; Cook N
    Circulation; 2005 Feb; 111(5):657-8. PubMed ID: 15699285
    [No Abstract]   [Full Text] [Related]  

  • 3. Applying the new cholesterol guidelines to your practice.
    Geisler SL
    JAAPA; 2001 Nov; 14(11):12-4, 17-8, 21-3. PubMed ID: 11766422
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipids and CVD management: towards a global consensus.
    Ballantyne C; Arroll B; Shepherd J
    Eur Heart J; 2005 Nov; 26(21):2224-31. PubMed ID: 15972289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary heart disease in women: update 2008.
    Wenger NK; Shaw LJ; Vaccarino V
    Clin Pharmacol Ther; 2008 Jan; 83(1):37-51. PubMed ID: 18043680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management.
    Davidson MH
    Postgrad Med; 2004 Sep; 116(3 Suppl):7-12. PubMed ID: 19667670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of HDL cholesterol increase for the risk reduction. Methods of intervention. recommendations of experts].
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II5-12. PubMed ID: 19813328
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing risk for coronary heart disease: beyond Framingham.
    Cobb FR; Kraus WE; Root M; Allen JD
    Am Heart J; 2003 Oct; 146(4):572-80. PubMed ID: 14564309
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of coronary heart disease and the National Cholesterol Education Program.
    Kuller LH
    Circulation; 2006 Feb; 113(5):598-600. PubMed ID: 16461829
    [No Abstract]   [Full Text] [Related]  

  • 12. Using nontraditional risk factors in coronary heart disease risk assessment.
    Lin KW; Garcia SM
    Am Fam Physician; 2011 Feb; 83(4):449. PubMed ID: 21322521
    [No Abstract]   [Full Text] [Related]  

  • 13. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
    Ridker PM
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1222-4. PubMed ID: 18565847
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two approaches of coronary risk assessment--do they work?
    Ajani UA; Ford ES
    Am J Cardiol; 2006 Mar; 97(6):765-7. PubMed ID: 16516571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of CHD: the role of elevated triglycerides.
    Watson KE
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):4-6, 13-4. PubMed ID: 18510281
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary heart disease risk assessment by traditional risk factors and newer subclinical disease imaging: is a "one-size-fits-all" approach the best option?
    Preis SR; O'Donnell CJ
    Arch Intern Med; 2007 Dec; 167(22):2399-401. PubMed ID: 18071160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.